Cargando…

Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies

Detalles Bibliográficos
Autores principales:	Hahn, Virginia Shalkey, Lenihan, Daniel J., Ky, Bonnie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Contemporary Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187516/ https://www.ncbi.nlm.nih.gov/pubmed/24755151 http://dx.doi.org/10.1161/JAHA.113.000665

Ejemplares similares

Cardiotoxicity From Human Epidermal Growth Factor Receptor‐2 (HER2) Targeted Therapies
por: Florido, Roberta, et al.
Publicado: (2017)

Inequity in Cardio‐Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes
por: Ohman, Rachel E., et al.
Publicado: (2021)

Device‐Based Approaches Targeting Cardioprotection in Myocardial Infarction: The Expanding Armamentarium of Innovative Strategies
por: Romeo, Francisco José, et al.
Publicado: (2022)

Epicardial and Perivascular Adipose Tissues and Their Influence on Cardiovascular Disease: Basic Mechanisms and Clinical Associations
por: Fitzgibbons, Timothy P., et al.
Publicado: (2014)

Common Statistical Pitfalls in Basic Science Research
por: Sullivan, Lisa M., et al.
Publicado: (2016)

Scavenger Receptors in Myocardial Infarction and Ischemia/Reperfusion Injury: The Potential for Disease Evaluation and Therapy
por: Zhang, Jishou, et al.
Publicado: (2023)

Magnetic seizure therapy
por: Singh, Rishabh, et al.
Publicado: (2021)

The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity
por: Küçük, Murathan, et al.
Publicado: (2020)

Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
por: Morelli, Marco Bruno, et al.
Publicado: (2022)

Overcoming Challenges With Statin Therapy
por: Spence, J. David, et al.
Publicado: (2016)

The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
por: Omland, Torbjørn, et al.
Publicado: (2022)

Gene Therapy to Treat Cardiovascular Disease
por: Wolfram, Julie A., et al.
Publicado: (2013)

Human Pluripotent Stem Cells for Modeling of Anticancer Therapy-Induced Cardiotoxicity and Cardioprotective Drug Discovery
por: Keung, Wendy, et al.
Publicado: (2021)

Current Landscape of Heart Failure Gene Therapy
por: Kieserman, Jake M., et al.
Publicado: (2019)

Characteristics of Older Adults Who Meet the Annual Prescription Drug Expenditure Threshold for Medicare Medication Therapy Management Programs
por: Daniel, Gregory W., et al.
Publicado: (2007)

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
por: Timm, Kerstin N., et al.
Publicado: (2020)

Emerging Therapies for Recurrent Pericarditis: Interleukin‐1 inhibitors
por: Lo Presti, Saberio, et al.
Publicado: (2021)

20902 Elucidation of Cardioprotective Mechanisms via Human Models of Chemotherapy-Induced Cardiotoxicity
por: Uche, Nnamdi, et al.
Publicado: (2021)

Cardiotoxicity and Cardioprotection by Artesunate in Larval Zebrafish
por: Zheng, Chuanrui, et al.
Publicado: (2020)

Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection
por: Deidda, Martino, et al.
Publicado: (2019)

Intravascular Imaging for Guiding In‐Stent Restenosis and Stent Thrombosis Therapy
por: Erdogan, Emrah, et al.
Publicado: (2022)

Pharmaceutical Step-Therapy Interventions: A Critical Review of the Literature
por: Motheral, Brenda R.
Publicado: (2011)

A Review of the Use of CAM Therapy and the Sources of Accurate and Reliable Information
por: McHuges, Mary, et al.
Publicado: (2005)

The Advancing Field of Cell‐Based Therapy: Insights and Lessons From Clinical Trials
por: Telukuntla, Kartik S., et al.
Publicado: (2013)

Twenty Years of Experience and Counting: Strategies for Growing Medication Therapy Management Services
por: Brummel, Amanda R., et al.
Publicado: (2020)

How to Apply Translational Models to Probe Mechanisms of Cardiotoxicity
por: Livingston, Carissa E., et al.
Publicado: (2022)

Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach
por: Verdonschot, Job A. J., et al.
Publicado: (2019)

Assessment of Clinical Pharmacist Management of Lipid-Lowering Therapy in a Primary Care Setting
por: Till, Traywick L, et al.
Publicado: (2003)

Memory: Neurobiological mechanisms and assessment
por: Mujawar, Swaleha, et al.
Publicado: (2021)

The Cardioprotective Mechanism of Phenylaminoethyl Selenides (PAESe) Against Doxorubicin-Induced Cardiotoxicity Involves Frataxin
por: Fu, Xiaoyu, et al.
Publicado: (2021)

Cardioprotective potential of mitochondria-targeted antioxidant, mito-TEMPO, in 5-fluorouracil-induced cardiotoxicity
por: Tambe, Prasad Kisan, et al.
Publicado: (2023)

The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy
por: Zilinyi, Rita, et al.
Publicado: (2018)

Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity
por: Liu, Yihai, et al.
Publicado: (2021)

Opinions of a Small Sample of Pharmacists About Pharmacy Setting and Patient Adherence to Antiretroviral Therapy
por: Kibicho, Jennifer, et al.
Publicado: (2012)

Cardiovascular Effects of Snake Toxins: Cardiotoxicity and Cardioprotection
por: Averin, A. S., et al.
Publicado: (2021)

Medication Monitoring and Optimization: A Targeted Pharmacist Program for Effective and Cost-Effective Improvement of Chronic Therapy Adherence
por: van Boven, Job F.M., et al.
Publicado: (2014)

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy—Current Data and Future Directions
por: Spinthakis, Nikolaos, et al.
Publicado: (2018)

All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart
por: Li, Junlang, et al.
Publicado: (2021)

Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy
por: Vaduganathan, Muthiah, et al.
Publicado: (2019)

How do nurses better predict outcomes for adult COVID-19 patients receiving nasal high flow therapy in the emergency care setting?
por: ODonnell, Jane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uq8rh5nmcatk4g0ej5fc9029tb